The goal of the center is to use outbred rats to study the genetic basis of drug self-administration and related behavioral traits. More information is available at www.ratgenes.org.
A new R01 grant from the National Eye Institute was awarded to Drs. Monica Jablonski, Abraham Palmer, and several others. The grant is titled, “Genetic Modulators of Glaucoma.” Dr. Monica Jablonski (Department of Ophthalmology at the University of Tennessee) received
A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Drs. Abraham Palmer, Dongjun Chung, Roberto Ciccocioppo, Gerard Thomas Hardiman, Peter Kalivas, and Leah Catherine Solberg Woods. The grant is titled “The Genetic Basis of
Sandra’s project, titled “CADM2, a cell adhesion molecule, and its association with risk and psychopathology,” was selected for funding by the Brain & Behavior Research Foundation. The NARSAD Young Investigator Grant provides support for the most promising young scientists conducting neurobiological research.
Dr. Abraham Palmer was awarded an R01 grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for his project titled “A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement.” This is a five year grant
Dr. Abraham Palmer was awarded a High Impact Research Project Award from the California Tobacco Related-Disease Research Program (TRDRP) for his project titled “Genetic relationship between impulsivity and nicotine abuse.” This is a three year, $750,000 grant that starts July
A U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Robert Hitzemann, Dr. Suzanne Mitchell, and Dr. Abraham Palmer. The grant, titled “Identification of genetic features of delay discounting using a heterogeneous stock rat model,” will
The NIH’s National Institute on Drug Abuse (NIDA) recently awarded the Scripps Research team two separate grants totaling $7.5 million. The five-year grants will allow the researchers, led by Dr. Olivier George, to combine next-generation sequencing with rodent behavioral screening in a
A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Tom Jhou and Dr. Abraham Palmer. The grant, titled “Genomic Analysis of Avoidance Learning in Addiction,” will start on April 15, 2018 and will
A new U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Olivier George from TSRI. Dr. Palmer is a co-investigator on this project, which will use HS rats to perform a GWAS for extended access to